Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBatm Advanced Regulatory News (BVC)

Share Price Information for Batm Advanced (BVC)

Share Price is delayed by 15 minutes
Get Live Data
12.60    -0.05 (-0.40%)
Bid:
12.60
Ask:
12.95
Spread: 0.35 (2.778%)
Market Cap: £42.85m
BVC Live PriceLast checked at - London Stock Exchange

Intraday Batm Advanced Share Chart

Interim Management Statement

26 Oct 2011 07:01

RNS Number : 8371Q
BATM Advanced Communications Ld
26 October 2011
 



26 October 2011

 

BATM Advanced Communications Limited

Interim Management Statement

BATM Advanced Communications Limited ("BATM" or the "Company") (LSE: BVC), a leading designer and producer of telecom systems and medical laboratory diagnostic systems, is today issuing its Interim Management Statement for the period from 1 July 2011 to 30 September 2011.

Current trading update 

Total revenues in the third quarter of 2011 (Q3) were $30.4 million, compared with $29.0 million in the equivalent period in 2010. This 5.0% increase in turnover during Q3 brings revenues for the nine months to September 30 to $95.0 million, an increase of 12.7% over the same period in 2010.

 

During the third quarter of the year the sales mix was 65% from the Telecoms division and 35% from the Medical division, compared to 68% and 32% respectively in the third quarter of 2010. Gross margin was slightly higher during the third quarter of 2011 over the same period last year.

 

Within the Telecom division the OEM business with Nokia Siemens Networks is expected to further decline in the coming quarter and this will impact the profitability of the Telecom division. The announcement made today regarding the signing of a major new global OEM vendor demonstrates the Company's commitment to and confidence in rebuilding the profitability of this aspect of the division.

 

Despite the uncertain global economic outlook, the Company continues to generate new business opportunities in both the Medical and Telecom divisions, and the Board expects this to continue. 

 

Financial position 

The Company's balance sheet remains strong and as at October 24 the effective cash balance stood at $46.1 million, a decrease of $8.6 million compared to the position at 30 June 2011, mainly as a result of dividends and related tax payments of $5.8 million, and increased inventory of $1.5 million, which includes those of the ANDA Networks assets acquired in April.

 

New agreement signed

As announced this morning, we are pleased to have signed a new OEM agreement with the world's largest tier 1 telecom vendor. The agreement will see this leading vendor sell our Carrier Ethernet Access products through its many locations around the world. We believe this agreement demonstrates that our strategy of seeking alternative channels to the declining Nokia Siemens Networks business is succeeding. We expect to start generating significant revenues from this contract during 2012.

 

New Listing

The Company has received approval from the Tel-Aviv Stock Exchange to dual list its shares there. We expect that the listing will become effective and trading will commence on this market before the end of the year, as previously announced.

 

Outlook  

The Board believes that the performance for the last quarter of this year will be similar to the third quarter, rather than the comparable period last year which was particularly strong. Therefore, we believe that the second half performance will be broadly in line with the first half of the year and as a result guidance for full year revenues will likely be in the region of $130 million with corresponding operating profit excluding amortisation of intangibles of $7.0 million.

 

 

 

- Ends -

 

Enquiries

 

BATM Advanced Communications +972 9866 2525   

Dr Zvi Marom, Chief Executive

Ofer Bar-Ner, CFO

 

Threadneedle Communications 020 7653 9850

Josh Royston / Graham Herring

 

finnCap 020 7220 0500

Marc Young / Brian Patient

 

Shore Capital 020 7408 4090 

Pascal Keane

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSBLBDGGUDBGBU
Date   Source Headline
14th Apr 20229:30 amRNSAnnual Financial Report
13th Apr 20227:00 amRNSAppointment of Non-Executive Director
4th Apr 20227:00 amRNSTransaction in Own Shares and TVR
18th Mar 20227:00 amRNSStrategic Partnership for Edgility with NEXCOM
17th Mar 202210:30 amRNSResult of General Meeting
10th Mar 202212:30 pmRNSHolding(s) in Company
8th Mar 202211:30 amRNSHolding(s) in Company
28th Feb 20227:00 amRNSFull Year Results
23rd Feb 20227:00 amRNSNotice of General Meeting
21st Feb 20227:00 amRNSStrategic Partnership for Edgility with Advantech
17th Feb 20227:00 amRNSTrading Update and Notice of Results
3rd Feb 202211:23 amRNSClarification on FTSE Nationality Review
3rd Feb 20227:00 amRNSUpdate on FTSE Nationality Review & Share Buyback
31st Jan 20227:00 amRNSUpdate on Ador Diagnostics
17th Jan 20227:00 amRNSUpdate on FTSE Nationality Review
4th Jan 20227:00 amRNSDividend Declaration
4th Jan 20227:00 amRNSTotal Voting Rights
16th Dec 20217:00 amRNSFirst sales of rapid COVID-19 test in Russia
14th Dec 202111:45 amRNSResult of AGM and Dividend Declaration
30th Nov 20217:00 amRNSCOVID-19 tests effective in diagnosing Omicron
25th Nov 20213:00 pmRNSBlock Listing Interim Review
22nd Nov 20213:00 pmRNSNotice of AGM and Dividend Declaration
10th Nov 20217:00 amRNSBATM receives $3.5m cyber security contract
3rd Nov 20217:00 amRNSNew five-year contract for Edgility
1st Nov 20217:00 amRNSBATM receives agri-waste contract in Botswana
7th Oct 20217:00 amRNSStrategic partnership for NFV with AudioCodes
13th Sep 20217:00 amRNSFirst enterprise customer for NFV with $2m order
23rd Aug 20217:00 amRNSInterim Results
12th Aug 20217:00 amRNSNotice of Results
12th Jul 20217:00 amRNSLaunch of Edgility networking NFV-based ecosystem
5th Jul 20217:00 amRNSBATM receives $10m cyber security contract
15th Jun 20217:00 amRNSBATM receives $4.1m cyber security contract
26th May 20217:00 amRNSBlock listing Interim Review
18th May 20217:00 amRNSBATM commences delivery of new COVID-19 tests
19th Apr 202110:25 amRNSAnnual Financial Report
12th Apr 20217:00 amRNSStrategic partnership for NFV
29th Mar 20217:00 amRNSBATM develops molecular diagnostics test for TB
19th Mar 20217:00 amRNSCompletion of Sale of NGSoft
11th Mar 20217:00 amRNSBATM launches no-swab saliva-based COVID-19 test
1st Mar 20217:00 amRNSUpdate on Sale of NGSoft
22nd Feb 20217:00 amRNSFull Year Results
11th Feb 20215:38 pmRNSFTSE Nationality Review
1st Feb 20217:00 amRNSTrading Update and Notice of Results
19th Jan 20217:00 amRNSBATM's NFVTime now available for the public cloud
12th Jan 20217:00 amRNSBATM enters option agreement to sell NGSoft
24th Dec 20207:00 amRNSCOVID-19 test effective in diagnosing new strain
17th Dec 20203:50 pmRNSResult of AGM
15th Dec 20207:00 amRNSUpdate on Ador Diagnostics
7th Dec 20207:00 amRNSDelivery of First Insect Protein Recovery Facility
30th Nov 20203:03 pmRNSTotal Voting Rights and Share Capital

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.